Non-invasive and Continuous Blood Pressure Monitoring
Launched by VENA VITALS · Mar 13, 2025
Trial Information
Current as of April 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients whose blood pressure will be monitored using an arterial line during their procedure
- • Patients who have a palpable dorsalis pedis pulse
- Exclusion Criteria:
- • Patients who have non-palpable dorsalis pedis pulses
- • Patients whose limbs are inaccessible for placement of Vena Vitals Wearable
- • Patients with known allergy to adhesives and/or silicone
About Vena Vitals
Vena Vitals is a pioneering clinical trial sponsor dedicated to advancing healthcare through innovative research and development. With a focus on enhancing patient outcomes, Vena Vitals specializes in conducting rigorous clinical studies that evaluate cutting-edge medical technologies and therapies. Our team of experienced professionals is committed to upholding the highest standards of integrity and compliance, ensuring that all trials are executed with precision and care. By fostering collaborations with healthcare providers, researchers, and regulatory bodies, Vena Vitals aims to accelerate the delivery of transformative solutions to the medical community and improve the quality of life for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Philadelphia, Pennsylvania, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Related Blog Entries
View all
